Frog-Derived Peptide Shows Promise as Sepsis Treatment in Mice
Cathelicidin-MH, a novel antimicrobial peptide from frog skin, protected mice from lethal sepsis by combining antimicrobial activity, LPS neutralization, and coagulation suppression.
Quick Facts
What This Study Found
Cathelicidin-MH protected mice from lethal sepsis through a unique combination of antimicrobial activity, LPS neutralization, coagulation suppression (affecting tPA, plasmin, tryptase, elastase, thrombin, and chymase), and MAPK signaling inhibition.
Key Numbers
Active vs Gram-negatives and fungi; 6 coagulation enzymes inhibited; 2 sepsis models; reduced cytokines; blocked MAPK
How They Did This
Peptide isolation and structural characterization. In vitro antimicrobial and coagulation assays. In vivo LPS-induced and cecal ligation/puncture sepsis models in mice. Organ pathology, inflammatory cytokine, and signaling pathway analysis.
Why This Research Matters
Sepsis kills more than 11 million people annually and current treatments are limited. A peptide that simultaneously fights infection, neutralizes endotoxin, and controls coagulation addresses multiple sepsis mechanisms at once.
The Bigger Picture
Most antimicrobial peptides are studied for their direct killing activity, but cath-MH's additional coagulation-suppressing and anti-inflammatory properties make it especially suited for sepsis, where uncontrolled coagulation and inflammation are major drivers of organ failure and death.
What This Study Doesn't Tell Us
Mouse sepsis models don't perfectly predict human sepsis outcomes. Peptide stability, pharmacokinetics, and manufacturing costs not addressed. Published in eLife (high-quality journal) but still preclinical.
Questions This Raises
- ?Can cath-MH be produced at scale for clinical use?
- ?Would the coagulation-suppressing effects increase bleeding risk at therapeutic doses?
- ?How does cath-MH compare to other anti-sepsis peptide candidates?
Trust & Context
- Key Stat:
- Multi-mechanism sepsis protection Combines antimicrobial killing, LPS neutralization, coagulation suppression, and MAPK signaling inhibition
- Evidence Grade:
- Published in eLife with comprehensive in vitro and in vivo validation including two sepsis models. High-quality preclinical evidence.
- Study Age:
- Published in 2021, representing cutting-edge antimicrobial peptide research from amphibian sources.
- Original Title:
- Characterization and functional analysis of cathelicidin-MH, a novel frog-derived peptide with anti-septicemic properties.
- Published In:
- eLife, 10 (2021)
- Authors:
- Chai, Jinwei(3), Chen, Xin(3), Ye, Tiaofei, Zeng, Baishuang, Zeng, Qingye, Wu, Jiena, Kascakova, Barbora, Martins, Larissa Almeida, Prudnikova, Tatyana, Smatanova, Ivana Kuta, Kotsyfakis, Michail, Xu, Xueqing
- Database ID:
- RPEP-05307
Evidence Hierarchy
Frequently Asked Questions
Why is a frog skin peptide useful for treating sepsis?
Frogs produce antimicrobial peptides in their skin as part of their immune defense. Cathelicidin-MH from the Microhyla frog is unique because it doesn't just kill bacteria — it also neutralizes bacterial toxins, controls blood clotting, and reduces inflammation, addressing multiple aspects of sepsis simultaneously.
How is this different from antibiotics for sepsis?
Antibiotics kill bacteria but don't address the other deadly aspects of sepsis — the toxin release, uncontrolled clotting, and inflammatory organ damage. Cath-MH tackles all of these at once, which could make it more effective as a sepsis therapeutic.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05307APA
Chai, Jinwei; Chen, Xin; Ye, Tiaofei; Zeng, Baishuang; Zeng, Qingye; Wu, Jiena; Kascakova, Barbora; Martins, Larissa Almeida; Prudnikova, Tatyana; Smatanova, Ivana Kuta; Kotsyfakis, Michail; Xu, Xueqing. (2021). Characterization and functional analysis of cathelicidin-MH, a novel frog-derived peptide with anti-septicemic properties.. eLife, 10. https://doi.org/10.7554/eLife.64411
MLA
Chai, Jinwei, et al. "Characterization and functional analysis of cathelicidin-MH, a novel frog-derived peptide with anti-septicemic properties.." eLife, 2021. https://doi.org/10.7554/eLife.64411
RethinkPeptides
RethinkPeptides Research Database. "Characterization and functional analysis of cathelicidin-MH,..." RPEP-05307. Retrieved from https://rethinkpeptides.com/research/chai-2021-characterization-and-functional-analysis
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.